V.J. Gnanapragasam

501 total citations
18 papers, 388 citations indexed

About

V.J. Gnanapragasam is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, V.J. Gnanapragasam has authored 18 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in V.J. Gnanapragasam's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). V.J. Gnanapragasam is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). V.J. Gnanapragasam collaborates with scholars based in United Kingdom. V.J. Gnanapragasam's co-authors include Craig Robson, Hing Y. Leung, David E. Neal, Steven Darby, Anne T. Collins, Kanagasabai Sahadevan, David Thurtle, Paul Cross, Ali Kucukmetin and Sarah Wilkinson and has published in prestigious journals such as The Journal of Pathology, BMC Medicine and Human Pathology.

In The Last Decade

V.J. Gnanapragasam

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.J. Gnanapragasam United Kingdom 10 201 179 70 59 57 18 388
Harry Fisher United States 8 136 0.7× 164 0.9× 89 1.3× 45 0.8× 30 0.5× 11 442
Wolter Oosterhuis Netherlands 13 256 1.3× 97 0.5× 57 0.8× 91 1.5× 134 2.4× 19 522
F Desangles France 9 339 1.7× 90 0.5× 77 1.1× 106 1.8× 83 1.5× 18 552
Terri Woo United States 7 135 0.7× 31 0.2× 129 1.8× 85 1.4× 51 0.9× 8 394
Lixin Hua China 11 159 0.8× 124 0.7× 76 1.1× 111 1.9× 10 0.2× 43 356
Jean Kao United States 10 286 1.4× 249 1.4× 69 1.0× 136 2.3× 39 0.7× 12 559
Sunny Hartwig Canada 12 515 2.6× 161 0.9× 20 0.3× 72 1.2× 146 2.6× 19 623
Stacy Ugras United States 9 204 1.0× 166 0.9× 157 2.2× 246 4.2× 40 0.7× 20 589
Çiğdem Himmetoğlu Türkiye 11 163 0.8× 49 0.3× 109 1.6× 35 0.6× 143 2.5× 17 407
Constantine Milathianakis Greece 12 83 0.4× 175 1.0× 134 1.9× 65 1.1× 23 0.4× 18 334

Countries citing papers authored by V.J. Gnanapragasam

Since Specialization
Citations

This map shows the geographic impact of V.J. Gnanapragasam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.J. Gnanapragasam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.J. Gnanapragasam more than expected).

Fields of papers citing papers by V.J. Gnanapragasam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.J. Gnanapragasam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.J. Gnanapragasam. The network helps show where V.J. Gnanapragasam may publish in the future.

Co-authorship network of co-authors of V.J. Gnanapragasam

This figure shows the co-authorship network connecting the top 25 collaborators of V.J. Gnanapragasam. A scholar is included among the top collaborators of V.J. Gnanapragasam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.J. Gnanapragasam. V.J. Gnanapragasam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Parry, Matthew G., Thomas E. Cowling, Arunan Sujenthiran, et al.. (2020). Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation. BMC Medicine. 18(1). 114–114. 23 indexed citations
2.
Gnanapragasam, V.J., et al.. (2019). Use of the PHI assay as a first line triaging test in an image-guided prostate cancer diagnostic pathway. The PHI in Refining MRI (PRIM) study. European Urology Supplements. 18(1). e129–e129. 2 indexed citations
3.
4.
Thurtle, David, Tristan Barrett, Bo Kyung Koo, et al.. (2018). Progression and treatment rates using an active surveillance protocol incorporating image guided baseline biopsies and multi-parametric MRI monitoring for men with favourable risk prostate cancer. European Urology Supplements. 17(2). e1895–e1896. 4 indexed citations
5.
Jaulim, Adil, et al.. (2018). A comparison of operative and margin outcomes from surgeon learning curves in robot assisted radical prostatectomy in a changing referral practice. Annals of The Royal College of Surgeons of England. 100(3). 226–229. 12 indexed citations
6.
7.
Gnanapragasam, V.J., et al.. (2016). 384 The Prostate Health Index (PHI) predicts positive cancer biopsies in men with a negative mpMRI in a repeat biopsy population. European Urology Supplements. 15(3). e384–e384. 1 indexed citations
8.
Gnanapragasam, V.J., et al.. (2012). Polymyalgia rheumatica following robotic radical prostatectomy. International Journal of Surgery Case Reports. 3(8). 354–355.
9.
Gnanapragasam, V.J., et al.. (2010). Does a Pre-Operative Urodynamic Diagnosis of Bladder Outflow Obstruction Improve Outcomes from Palliative Transurethral Prostatectomy?. Urologia Internationalis. 86(1). 85–89. 5 indexed citations
10.
Wilkinson, Sarah, Ali Kucukmetin, Paul Cross, et al.. (2008). Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer. Human Pathology. 39(8). 1197–1204. 22 indexed citations
11.
Cole, Michael, et al.. (2008). PROGNOSTIC FACTORS FOR BIOCHEMICAL RELAPSE IN A CONTEMPORARY COHORT OF MEN TREATED BY HORMONAL ABLATION MONOTHERAPY. European Urology Supplements. 7(3). 236–236. 1 indexed citations
12.
Darby, Steven, Craig Robson, Hing Y. Leung, & V.J. Gnanapragasam. (2008). THE SEF LONG ISOFORM A IS A KEY INHIBITOR OF FGF INDUCED TUMOURIGENIC BEHAVIOUR THROUGH INHIBITION OF MULTIPLE SIGNALLING PATHWAYS IN PROSTATE CANCER. European Urology Supplements. 7(3). 173–173. 1 indexed citations
13.
Darby, Steven, et al.. (2007). Expression of GnRH type II is regulated by the androgen receptor in prostate cancer. Endocrine Related Cancer. 14(3). 613–624. 16 indexed citations
14.
Sahadevan, Kanagasabai, et al.. (2007). Selective over‐expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer. The Journal of Pathology. 213(1). 82–90. 93 indexed citations
15.
16.
Gnanapragasam, V.J., Craig Robson, Hing Y. Leung, & David E. Neal. (2000). Androgen receptor signalling in the prostate. British Journal of Urology. 86(9). 1001–1013. 48 indexed citations
17.
Gnanapragasam, V.J., Philip McCahy, David E. Neal, & Craig Robson. (2000). Insulin‐like growth factor II and androgen receptor expression in the prostate. British Journal of Urology. 86(6). 731–735. 13 indexed citations
18.
Robson, Craig, et al.. (1999). Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. Journal of Endocrinology. 160(2). 257–266. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harry Fisher Breakdown of academic impact, for papers by Wolter Oosterhuis Breakdown of academic impact, for papers by F Desangles Breakdown of academic impact, for papers by Terri Woo Breakdown of academic impact, for papers by Lixin Hua Breakdown of academic impact, for papers by Jean Kao Breakdown of academic impact, for papers by Sunny Hartwig Breakdown of academic impact, for papers by Stacy Ugras Breakdown of academic impact, for papers by Çiğdem Himmetoğlu Breakdown of academic impact, for papers by Constantine Milathianakis
Rankless by CCL
2026